6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Recurrent / Breakthrough ... DVT During Anticoagulation ... #VTE #anticoagulation ... #hematology #differential ... #algorithm
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... #Management #VTE ... #DVT #Algorithm ... #Treatment #Hematology ... #Anticoagulation
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... #Anticoagulation ... #Extension #VTE ... #DVT #Hematology ... #Management #Diagnosis
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... = venous thromboembolism ... #Anticoagulation ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Treatment Algorithm ... Isolated distal DVT ... therapy - Second VTE ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... megakaryocyte lineage ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #hematology